Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2019 | 10-2018 | 07-2018 | 04-2018 | 01-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,675 | 14,214 | 27,092 | -9,325 | -14,176 |
| Depreciation Amortization | 1,510 | 1,109 | 761 | 392 | 320 |
| Accounts receivable | -2,943 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 123 | -4,798 | -3,142 | 4,151 | 4,392 |
| Other Working Capital | -51,772 | -51,029 | -48,211 | -1,037 | -10,541 |
| Other Operating Activity | 10,858 | 11,473 | -454 | -3,861 | 889 |
| Operating Cash Flow | $-35,549 | $-29,031 | $-23,954 | $-9,680 | $-19,116 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -158 | -73 | -67 | -34 | -469 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -6,214 |
| Purchase Sale Intangibles | -8 | -7 | -7 | -7 | -155 |
| Other Investing Activity | -257 | -3 | -4 | -6 | -139 |
| Investing Cash Flow | $-415 | $-75 | $-71 | $-40 | $-6,822 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,103 | 19,593 | 20,094 | 20,763 | 19,941 |
| Other Financing Activity | -1,742 | -1,113 | -1,142 | -1,180 | -1,845 |
| Financing Cash Flow | $44,361 | $18,480 | $18,952 | $19,583 | $18,096 |
| Exchange Rate Effect | 567 | 1,469 | 1,117 | 565 | -2,517 |
| Beginning Cash Position | 26,669 | 26,080 | 26,750 | 27,642 | 36,520 |
| End Cash Position | 35,633 | 16,923 | 22,794 | 38,070 | 26,161 |
| Net Cash Flow | $8,963 | $-9,157 | $-3,956 | $10,428 | $-10,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,549 | -29,031 | -23,954 | -9,680 | -19,116 |
| Capital Expenditure | -158 | -73 | -67 | -34 | -469 |
| Free Cash Flow | -35,707 | -29,103 | -24,020 | -9,714 | -19,585 |